Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Echo Therapeutics, Inc. | w77925e10vk.htm |
| EX-21 - EX-21 - Echo Therapeutics, Inc. | w77925exv21.htm |
| EX-32.2 - EX-32.2 - Echo Therapeutics, Inc. | w77925exv32w2.htm |
| EX-32.1 - EX-32.1 - Echo Therapeutics, Inc. | w77925exv32w1.htm |
| EX-31.2 - EX-31.2 - Echo Therapeutics, Inc. | w77925exv31w2.htm |
| EX-31.1 - EX-31.1 - Echo Therapeutics, Inc. | w77925exv31w1.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements of Echo
Therapeutics, Inc. (formerly Sontra Medical Corporation) on Form S-8
(File Nos. 333-164510, 333-152138,
333-92414, 333-101517, 333-106201, 333-122893, 333-134674, 333-143145 and 333-146607), of our
report dated March 31, 2010, relating to the consolidated financial statements for the years ended
December 31, 2009 and 2008, which is part of this Form 10-K. Our report dated March 31, 2010
relating to the consolidated financial statements includes an emphasis paragraph relating to an
uncertainty as to the Company’s ability to continue as a going concern.
/s/ Wolf & Company,
P.C.
Boston, Massachusetts
March 31, 2010
Boston, Massachusetts
March 31, 2010